Turagam, M., Parikh, V., Afzal, M., Gopinathannair, R., Lavu, M., Kanmanthareddy, A., et al. (2017). Replacing warfarin with a novel oral anticoagulant: Risk of recurrent bleeding and stroke in patients with warfarin ineligible or failure in patients with atrial fibrillation (The ROAR study). JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 28(8), 853-861 [10.1111/jce.13254].

Replacing warfarin with a novel oral anticoagulant: Risk of recurrent bleeding and stroke in patients with warfarin ineligible or failure in patients with atrial fibrillation (The ROAR study)

Natale A;
2017-01-01

2017
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MEDS-07/B - Malattie dell'apparato cardiovascolare
English
Turagam, M., Parikh, V., Afzal, M., Gopinathannair, R., Lavu, M., Kanmanthareddy, A., et al. (2017). Replacing warfarin with a novel oral anticoagulant: Risk of recurrent bleeding and stroke in patients with warfarin ineligible or failure in patients with atrial fibrillation (The ROAR study). JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 28(8), 853-861 [10.1111/jce.13254].
Turagam, M; Parikh, V; Afzal, M; Gopinathannair, R; Lavu, M; Kanmanthareddy, A; Pillarisetti, J; Reddy, M; Atkins, D; Bommana, S; Jaeger, M; Jeffery, ...espandi
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/417683
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 5
social impact